title: [Recent trends in first-line therapy for H. pylori infection in the world].
authors.affiliation: Department of Clinical Molecular Medicine, Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine.
authors.forename: Ikuya
authors.initials: I
authors.lastname: Miki
authors.forename: Daisuke
authors.initials: D
authors.lastname: Shirasaka
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Morita
authors.forename: Nobuo
authors.initials: N
authors.lastname: Aoyama
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D014943:Global Health; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010349:Patient Compliance; D054328:Proton Pump Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors